Sage Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SAGE and buy or sell other stocks, ETFs, and their options commission-free!About SAGE
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain.
CEOBarry E. Greene, MD
CEOBarry E. Greene, MD
Employees353
Employees353
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees353
Employees353
SAGE Key Statistics
Market cap543.61M
Market cap543.61M
Price-Earnings ratio-1.77
Price-Earnings ratio-1.77
Dividend yield—
Dividend yield—
Average volume3.47M
Average volume3.47M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$9.36
52 Week high$9.36
52 Week low$4.62
52 Week low$4.62
Stock Snapshot
Sage Therapeutics(SAGE) stock is priced at $8.68, giving the company a market capitalization of 543.61M. It carries a P/E multiple of -1.77.
During the trading day, Sage Therapeutics(SAGE) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 3.47M.
Over the past 52 weeks, Sage Therapeutics(SAGE) stock has traded between a high of $9.36 and a low of $4.62.
Over the past 52 weeks, Sage Therapeutics(SAGE) stock has traded between a high of $9.36 and a low of $4.62.
People also own
Based on the portfolios of people who own SAGE. This list is generated using Robinhood data, and it’s not a recommendation.